Clinical trial
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
NCT01192503 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Rasagiline in Restless Legs Syndrome
- Lead sponsor
- University of Virginia
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- September 30, 2010
- Completion date
- August 31, 2012
- Enrollment
- 52 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.